VT02956 |
| Catalog No.GC70131 |
VT02956 est un inhibiteur de LATS (IC50 : 0,76 nM pour LATS1 et 0,52 nM pour LATS2). VT02956 cible la voie de signalisation Hippo. VT02956 inhibe la croissance des lignées cellulaires du cancer du sein ER+ et des organoïdes tumoraux provenant de patients ainsi que l'expression d'ESR1.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for VT02956
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for VT02956
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *